What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis?

Aydin F., ÇAKAR N., Kurt T., Acar B. C., Celikel E., Ozcakar Z. B., ...More

CLINICAL RHEUMATOLOGY, vol.41, no.12, pp.3791-3796, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 12
  • Publication Date: 2022
  • Doi Number: 10.1007/s10067-022-06327-4
  • Journal Name: CLINICAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.3791-3796
  • Keywords: Intra-articular corticosteroid injection, Juvenile idiopathic arthritis, Remission, TRIAMCINOLONE HEXACETONIDE, EFFICACY, CHILDREN, MANAGEMENT, THERAPY, PLUS
  • Ankara University Affiliated: Yes

Abstract

Introduction Intra-articular corticosteroid injection (IACI) is generally used in the management of juvenile idiopathic arthritis (JIA) to obtain rapid relief of active synovitis and functional recovery and to prevent the need for regular systemic therapy. The aim of this study was to investigate the outcome of IACI treatment and the factors associated with remission of synovitis.